Cite
Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease measured by chemiluminescence immunoassay.
MLA
Cao, Ying, et al. “Serum Oncostatin M Is a Potential Biomarker of Disease Activity and Infliximab Response in Inflammatory Bowel Disease Measured by Chemiluminescence Immunoassay.” Clinical Biochemistry, vol. 100, Feb. 2022, pp. 35–41. EBSCOhost, https://doi.org/10.1016/j.clinbiochem.2021.11.011.
APA
Cao, Y., Dai, Y., Zhang, L., Wang, D., Yu, Q., Hu, W., Wang, X., Yu, P., Ping, Y., Sun, T., Sang, Y., Liu, Z., Chen, Y., & Tao, Z. (2022). Serum oncostatin M is a potential biomarker of disease activity and infliximab response in inflammatory bowel disease measured by chemiluminescence immunoassay. Clinical Biochemistry, 100, 35–41. https://doi.org/10.1016/j.clinbiochem.2021.11.011
Chicago
Cao, Ying, Yibei Dai, Lingyu Zhang, Danhua Wang, Qiao Yu, Wen Hu, Xuchu Wang, et al. 2022. “Serum Oncostatin M Is a Potential Biomarker of Disease Activity and Infliximab Response in Inflammatory Bowel Disease Measured by Chemiluminescence Immunoassay.” Clinical Biochemistry 100 (February): 35–41. doi:10.1016/j.clinbiochem.2021.11.011.